• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA BC041954在卵巢癌中的表达及临床意义

Expression and clinical significance of lncRNA BC041954 in ovarian cancer.

作者信息

Lu Yan-Ming, Guo Ya-Ru, Zhou Meng-Ya, Wang Yue

机构信息

Department of Gynecology and Obstetrics, The Affiliated Shengjing Hospital, China Medical University, Shenyang, Liaoning 110003, P.R. China.

出版信息

Exp Ther Med. 2022 Jun;23(6):408. doi: 10.3892/etm.2022.11335. Epub 2022 Apr 26.

DOI:10.3892/etm.2022.11335
PMID:35619633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115623/
Abstract

Ovarian cancer (OC) is a highly lethal disease among all gynecologic malignant tumor types. Accumulating studies have indicated that certain long non-coding RNAs (lncRNAs) serve important roles in the development and progression of OC. In a previous study by our group, lncRNA BC041954 was identified as one of the most upregulated lncRNAs in OC. In the present study, the clinical significance of lncRNA BC041954 in OC was evaluated. The expression of BC041954 was detected in OC and non-tumor tissue (NT) samples using reverse transcription-quantitative PCR. Furthermore, the association between BC041954 and clinicopathological variables was analyzed using the Chi-square test. Survival was determined using Kaplan-Meier analysis. The prognostic significance of BC041954 was evaluated using univariate and multivariate logistic regression analyses. MicroRNA (miRNA)-lncRNA and miRNA-mRNA pairs were used to construct the lncRNA-miRNA-mRNA competing endogenous RNA network with an in-house Perl script. BC041954 expression was increased in 103 OC tissues as compared with that in NT tissues. Upregulated BC041954 expression was significantly associated with the International Federation of Gynecology and Obstetrics stage and distant metastasis. Kaplan-Meier analysis demonstrated that patients with high BC041954 expression had lower overall survival (OS). In the multivariate logistic regression analysis, BC041954 was also identified as an independent poor prognostic factor for OS in patients with OC. The results suggested that overexpression of the lncRNA BC041954 is a poor prognostic indicator in patients with OC.

摘要

在所有妇科恶性肿瘤类型中,卵巢癌(OC)是一种致死率很高的疾病。越来越多的研究表明,某些长链非编码RNA(lncRNA)在OC的发生和发展过程中发挥着重要作用。在我们团队之前的一项研究中,lncRNA BC041954被确定为OC中上调最为明显的lncRNA之一。在本研究中,对lncRNA BC041954在OC中的临床意义进行了评估。使用逆转录定量PCR检测OC和非肿瘤组织(NT)样本中BC041954的表达。此外,采用卡方检验分析BC041954与临床病理变量之间的关联。使用Kaplan-Meier分析确定生存率。采用单因素和多因素逻辑回归分析评估BC041954的预后意义。使用内部Perl脚本构建lncRNA- miRNA- mRNA竞争性内源RNA网络的miRNA- lncRNA和miRNA- mRNA对。与NT组织相比,103例OC组织中BC041954表达升高。BC041954表达上调与国际妇产科联合会分期和远处转移显著相关。Kaplan-Meier分析表明,BC041954高表达的患者总生存期(OS)较低。在多因素逻辑回归分析中,BC041954也被确定为OC患者OS的独立不良预后因素。结果表明,lncRNA BC041954的过表达是OC患者不良预后的指标。

相似文献

1
Expression and clinical significance of lncRNA BC041954 in ovarian cancer.长链非编码RNA BC041954在卵巢癌中的表达及临床意义
Exp Ther Med. 2022 Jun;23(6):408. doi: 10.3892/etm.2022.11335. Epub 2022 Apr 26.
2
Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.卵巢癌中失调的长非编码 RNA 和 mRNAs 的特征分析和验证。
Oncol Rep. 2018 Nov;40(5):2964-2976. doi: 10.3892/or.2018.6654. Epub 2018 Aug 17.
3
Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.长链非编码RNA SPRY4-IT1的上调预示卵巢癌预后不良并促进其肿瘤发生。
Biomed Pharmacother. 2017 Apr;88:529-534. doi: 10.1016/j.biopha.2017.01.037. Epub 2017 Jan 24.
4
A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer.一种潜在的卵巢癌免疫相关长链非编码RNA预后标志物
Front Genet. 2021 Jul 21;12:694009. doi: 10.3389/fgene.2021.694009. eCollection 2021.
5
Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer.竞争性内源性RNA网络的综合分析揭示了与上皮性卵巢癌相关的潜在预后生物标志物。
Oncol Lett. 2021 Dec;22(6):843. doi: 10.3892/ol.2021.13104. Epub 2021 Oct 21.
6
Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.竞争性内源性RNA网络鉴定出四种长链非编码RNA特征作为肺腺癌的候选预后生物标志物。
Transl Cancer Res. 2019 Aug;8(4):1046-1064. doi: 10.21037/tcr.2019.06.09.
7
Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.长链非编码RNA FAM83H-AS1在卵巢癌中的临床意义
Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4656-4662. doi: 10.26355/eurrev_201906_18045.
8
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.系统分析 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络鉴定出四个 lncRNA 特征作为乳腺癌的预后生物标志物。
J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2.
9
A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.一种基于共表达网络分析和五种长链非编码RNA表达水平的新型卵巢癌风险评分系统。
BMC Med Genet. 2019 Jun 10;20(1):103. doi: 10.1186/s12881-019-0832-9.
10
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.鉴定和验证一个与 m6A 相关的七个长链非编码 RNA 标志物,用于预测卵巢癌的预后。
BMC Cancer. 2022 Jun 8;22(1):633. doi: 10.1186/s12885-022-09591-4.

引用本文的文献

1
Latest Update on lncRNA in Epithelial Ovarian Cancer-A Scoping Review.上皮性卵巢癌中长链非编码RNA的最新进展——一项综述。
Cells. 2025 Apr 7;14(7):555. doi: 10.3390/cells14070555.
2
Angio-Long Noncoding RNA MALAT1 (rs3200401) and MIAT (rs1061540) Gene Variants in Ovarian Cancer.卵巢癌中的血管长链非编码RNA MALAT1(rs3200401)和MIAT(rs1061540)基因变异
Epigenomes. 2024 Jan 29;8(1):5. doi: 10.3390/epigenomes8010005.

本文引用的文献

1
Long noncoding RNA HOTAIR silencing inhibits invasion and proliferation of human colon cancer LoVo cells via regulating IGF2BP2.长链非编码RNA HOTAIR沉默通过调控IGF2BP2抑制人结肠癌LoVo细胞的侵袭和增殖。
J Cell Biochem. 2019 Feb;120(2):1221-1231. doi: 10.1002/jcb.27079. Epub 2018 Oct 18.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.卵巢癌中失调的长非编码 RNA 和 mRNAs 的特征分析和验证。
Oncol Rep. 2018 Nov;40(5):2964-2976. doi: 10.3892/or.2018.6654. Epub 2018 Aug 17.
4
The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis.lncRNA-HULC 多态性与肝细胞癌风险和预后的关联。
Gene. 2018 Sep 5;670:148-154. doi: 10.1016/j.gene.2018.05.096. Epub 2018 May 24.
5
Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity.乳腺癌相关 GAS5 和 LSINCT5 lncRNAs 在无癌乳腺组织中的表达水平:与初潮年龄和肥胖的分子关联。
Breast J. 2018 Nov;24(6):876-882. doi: 10.1111/tbj.13067. Epub 2018 May 21.
6
LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.LncRNA H19/miR-29b-3p/PGRN 轴通过作用于 Wnt 信号通路促进结直肠癌细胞上皮-间质转化。
Mol Cells. 2018 May 31;41(5):423-435. doi: 10.14348/molcells.2018.2258. Epub 2018 May 10.
7
Long noncoding RNA NORAD regulates transforming growth factor-β signaling and epithelial-to-mesenchymal transition-like phenotype.长链非编码 RNA NORAD 调控转化生长因子-β信号和上皮-间充质转化样表型。
Cancer Sci. 2018 Jul;109(7):2211-2220. doi: 10.1111/cas.13626. Epub 2018 May 29.
8
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.野生型 p53 通过 GAS7-CYFIP1 介导的信号通路上调早期乳腺癌相关基因 GAS7 以抑制转移。
Oncogene. 2018 Jul;37(30):4137-4150. doi: 10.1038/s41388-018-0253-9. Epub 2018 Apr 30.
9
Noncoding RNA:RNA Regulatory Networks in Cancer.非编码 RNA:癌症中的 RNA 调控网络。
Int J Mol Sci. 2018 Apr 27;19(5):1310. doi: 10.3390/ijms19051310.
10
Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.长链非编码 RNA 在卵巢癌中的作用:为治疗目的定义新的生物标志物。
Drug Discov Today. 2018 Sep;23(9):1635-1643. doi: 10.1016/j.drudis.2018.04.010. Epub 2018 Apr 23.